Published in Br J Obstet Gynaecol on July 01, 1993
Prevalence of hepatitis B and C viruses and human immunodeficiency virus infections in women of reproductive age. Br J Obstet Gynaecol (1992) 1.41
Functional homology of mammalian and yeast RAS genes. Cell (1985) 14.01
In yeast, RAS proteins are controlling elements of adenylate cyclase. Cell (1985) 11.63
Three different genes in S. cerevisiae encode the catalytic subunits of the cAMP-dependent protein kinase. Cell (1987) 6.35
Cloning and characterization of BCY1, a locus encoding a regulatory subunit of the cyclic AMP-dependent protein kinase in Saccharomyces cerevisiae. Mol Cell Biol (1987) 5.03
Effect of using protocols on medical care: randomised trial of three methods of taking an antenatal history. BMJ (1992) 4.07
Outbreak of HIV infection in a Scottish prison. BMJ (1995) 3.82
HCV confirmatory testing of blood donors. Lancet (1991) 3.29
Testing of blood donations for hepatitis C virus. Lancet (1994) 3.27
The structure of the major cell processes of isolated BHK21 fibroblasts. Exp Cell Res (1969) 3.27
Phagocytosis promotes programmed cell death in C. elegans. Nature (2001) 3.12
Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol (1995) 3.10
The occurrence of microvilli during spreading and growth of BHK21-C13 fibroblasts. Exp Cell Res (1970) 2.97
The DNA of a minute virus of mice. J Gen Virol (1969) 2.93
Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol (1994) 2.90
Viral hepatitis markers in blood donors and patients with a history of jaundice. Lancet (1980) 2.90
Rigorous feedback control of cAMP levels in Saccharomyces cerevisiae. Genes Dev (1987) 2.58
SCH9, a gene of Saccharomyces cerevisiae that encodes a protein distinct from, but functionally and structurally related to, cAMP-dependent protein kinase catalytic subunits. Genes Dev (1988) 2.57
A cumulative review of studies on travellers, their experience of illness and the implications of these findings. J Infect (1990) 2.50
Are preferences over health states complete? Health Econ (2000) 2.40
Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol (1993) 2.36
Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion (1993) 2.24
Virus replication in enucleate cells: vesicular stomatitis virus and influenza virus. J Virol (1974) 2.19
Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychol Med (2003) 2.16
Defective particles in BHK cells infected with temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1971) 2.14
Rapid one step urine test for human chorionic gonadotrophin in evaluating suspected complications of early pregnancy. BMJ (1991) 2.06
The DNAs of three parvoviruses. J Gen Virol (1970) 1.96
Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? J Infect (2000) 1.94
HTLV-III antibody in drug abusers in the west of Scotland: the Edinburgh connection. Lancet (1986) 1.88
An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1. AIDS (1989) 1.80
Birefringent filamentous organelle in BHK-21 cells and its possible role in cell spreading and motility. Science (1970) 1.78
Vaccinia virus replication in enucleate BSC-1 cells: particle production and synthesis of viral DNA and proteins. J Virol (1974) 1.72
Confirmation of hepatitis C virus antibody in blood donors. J Med Virol (1993) 1.68
Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J Biol Chem (2001) 1.67
Prevalence of maternal HIV infection in Scotland based on unlinked anonymous testing of newborn babies. Lancet (1991) 1.63
Murray River water, raised cyanobacterial cell counts, and gastrointestinal and dermatological symptoms. Med J Aust (1995) 1.62
Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie. AIDS (1995) 1.61
Vaccine prophylaxis of abattoir-associated Q fever. Lancet (1984) 1.55
Prevalence and epidemiological characteristics of hepatitis C in Scottish blood donors. Transfus Med (1994) 1.51
Molecular investigation into outbreak of HIV in a Scottish prison. BMJ (1997) 1.49
Virus development in enucleate cells: echovirus, poliovirus, pseudorabies virus, reovirus, respiratory syncytial virus and Semliki Forest virus. J Gen Virol (1975) 1.49
The incidence and prevalence of HIV infection among childbearing women living in Edinburgh city, 1982-1995. AIDS (1998) 1.48
Studies of RAS function in the yeast Saccharomyces cerevisiae. Cold Spring Harb Symp Quant Biol (1988) 1.48
Blood-donors with history of jaundice. Lancet (1979) 1.45
Ovarian cancer and infertility: a genetic link? Lancet (1999) 1.40
Langerhans' cells in the cervix. Am J Obstet Gynecol (1987) 1.39
Suture materials and subsequent wound strength. J Obstet Gynaecol (2008) 1.39
Antenatal screening for gonorrhoea in Christchurch. N Z Med J (1977) 1.38
Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: a cohort study. Am J Epidemiol (2004) 1.36
Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high. Commun Dis Public Health (1998) 1.35
Prevalence of intestinal parasitic infestation, salmonellosis, brucellosis, tuberculosis, and hepatitis B among immigrant children in Glasgow. Br Med J (1977) 1.32
Serological markers of hepatitis B in patients with alcoholic liver disease: a multi-centre survey. J Clin Pathol (1981) 1.27
A South Australian Salmonella Mbandaka outbreak investigation using a database to select controls. Aust N Z J Public Health (1998) 1.25
Outreach STD clinics for prostitutes in Edinburgh. Int J STD AIDS (1995) 1.25
Expression in Escherichia coli of BCY1, the regulatory subunit of cyclic AMP-dependent protein kinase from Saccharomyces cerevisiae. Purification and characterization. J Biol Chem (1987) 1.24
Health effects of exposure to cyanobacteria (blue-green algae) during recreational water-related activities. Aust N Z J Public Health (1997) 1.24
A comparison of the lytic action of Cytophaga johnsonii on a eubacterium and a yeast. Antonie Van Leeuwenhoek (1967) 1.23
Molecular epidemiology of human rotaviruses. Analysis of outbreaks of acute gastroenteritis in Glasgow and the west of Scotland 1981/82 and 1982/83. J Hyg (Lond) (1984) 1.22
A convenient method for enucleating cells in quantity. Exp Cell Res (1974) 1.19
Toward a national curriculum in informatics. Can Fam Physician (1998) 1.19
Extraordinary number of gene rearrangements in the mitochondrial genomes of lice (Phthiraptera: Insecta). Insect Mol Biol (2006) 1.18
Not all travellers need immunoglobulin for hepatitis A. Br Med J (Clin Res Ed) (1987) 1.16
Respiratory syncytial virus ts mutants and nuclear immunofluorescence. J Virol (1976) 1.15
A mutation in the catalytic subunit of cAMP-dependent protein kinase that disrupts regulation. Science (1988) 1.15
Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin. J Viral Hepat (2009) 1.14
Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. Br J Cancer (2009) 1.14
Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma. Br J Cancer (2011) 1.13
An inverse relation between cell density and the numner of microvilli in cultures of BHK 21 hamster fibroblasts. J Cell Sci (1970) 1.10
Events in vaccinia virus-infected cells following the reversal of the antiviral action of rifampicin. J Gen Virol (1970) 1.10
Human sentinels for arbovirus surveillance and regional risk classification in South Australia. Med J Aust (1994) 1.09
Detection of RNA complementary to herpes simplex virus DNA in human cervical squamous cell neoplasms. Cancer Res (1981) 1.07
Case report: pelvic pain syndrome--successful treatment of a case by ovarian vein embolization. Clin Radiol (1993) 1.06
Outcomes in rural obstetrics, Atherton Hospital 1991-2000. Aust J Rural Health (2001) 1.06
Neuropathy in multiple symmetric lipomatosis. Madelung's disease. Brain (1988) 1.05
Rates of subsequent surgery following endometrial ablation among English women with menorrhagia: population-based cohort study. BJOG (2014) 1.05
Evidence for previous hepatitis B virus infection in alcoholic cirrhosis. Br Med J (Clin Res Ed) (1981) 1.04
Gain-swept superradiance applied to the stand-off detection of trace impurities in the atmosphere. Proc Natl Acad Sci U S A (2005) 1.04
Electron microscope study of the denaturation of human papilloma virus DNA. II. The specific location of denatured regions. J Mol Biol (1967) 1.04
Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs). J Pathol (2008) 1.03
Trends in HCV prevalence among injecting drug users in Glasgow and Edinburgh during the era of needle/syringe exchange. Scand J Infect Dis (2001) 1.03
Pilot study of cervical cytology screening in a sexually transmitted diseases clinic. Genitourin Med (1985) 1.03
Cocirculation of different rotavirus strains in a local outbreak of infantile gastroenteritis: monitoring by rapid and sensitive nucleic acid analysis. J Med Virol (1983) 1.03
Action of interferon in enucleated cells. J Virol (1975) 1.03
Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate. Br J Cancer (1996) 1.02
The ultrastructural pathology of congenital murine toxoplasmic retinochoroiditis. Part II: The morphology of the inflammatory changes. Exp Eye Res (1986) 1.02
Cryptosporidial diarrhoea in South Australia. An exploratory case-control study of risk factors for transmission. Med J Aust (1993) 1.02
Electron microscope study of the denaturation of human papilloma virus DNA. I. Loss and reversal of supercoiling turns. J Mol Biol (1967) 1.02
Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data. J Viral Hepat (2013) 1.02
HCV confirmatory testing of blood donors. Lancet (1992) 1.02
Does using potting mix make you sick? Results from a Legionella longbeachae case-control study in South Australia. Epidemiol Infect (2006) 1.02
Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09. J Clin Virol (2013) 1.01
Inhibitory mechanisms of attention in identification and localization tasks: time course and disruption. J Exp Psychol Learn Mem Cogn (1991) 1.00
Hepatitis B outbreak at Glenochil prison during January to June 1993. Epidemiol Infect (1998) 1.00
Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis. J Viral Hepat (2005) 0.99
Maternal antibody to hepatitis B core antigen detected in dried neonatal blood spot samples. Epidemiol Infect (1998) 0.98
Electron microscope study of the denaturation of Polyoma virus DNA. J Mol Biol (1968) 0.98
Measurement of cell kinetics in cervical tumours using bromodeoxyuridine. Br J Cancer (1993) 0.98
An unusual steroid-producing ovarian tumour: case report. Hum Reprod (2002) 0.98
Hepatitis C antibody detection in dried blood spots. J Viral Hepat (1999) 0.97
Prevalence of HIV-1 infection among heterosexual men and women attending genitourinary clinics in Scotland: unlinked anonymous testing. BMJ (1997) 0.97